RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression

Rho GDP Dissociation Inhibitor (RhoGDI) is a key regulator of Rho GTPases. Here we report that loss of RhoGDI significantly accelerated xenograft tumor growth of MDA-MB-231 cells in animal models. At the molecular level, RhoGDI depletion resulted in constitutive activation of Rho GTPases, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozza, William P., Zhang, Yaqin, Hallett, Kory, Rosado, Leslie A. Rivera, Zhang, Baolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741725/
https://www.ncbi.nlm.nih.gov/pubmed/26416248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741725/
https://www.ncbi.nlm.nih.gov/pubmed/26416248

Ejemplares similares